Would you like to stay updated on news from PRAMO?
Deep Tech Award 2025: Berliner Unternehmen ausgezeichnet, darunter PRAMOMOLECULAR
Von der TU Berlin ins Unternehmertum: Fit für den Markt
Von der Beraterin
zur Chefin
Türöffner gegen Krebs
Shaping the Healthcare of Tomorrow with New Drugs Against ‘Undruggable Diseases’
Pushing the boundaries of
siRNA targeting and delivery
5 top Drug Development companies and startups in Germany in 2024
PRAMO one of the best
PRAMO is among the 14 best biotech start-ups at the EIT Health Catapult semifinals of the European Union.
Ready for Investment
PRAMO is eligible for the INVEST Grant. This allows national and international private investors to be reimbursed up to 15% of their capital invested in our company by BAFA- Federal Office of Economics and Export Control.
Spin OFFS To Watch 2021
Investment Information Sheet (IIS) in accordance with Sections 2a and 13 of the German Investment Products Act (VermAnlG) of PRAMOMOLECULAR GmbH
This document is an English translation of the original German version of the Vermögensanlagen-Informationsblatt (VIB). It is provided for informational purposes only and has no legal or official meaning. In case of any discrepancies or legal relevance, only the German version shall be binding.
